Literature DB >> 17521525

Progression and remission of nephropathy in type 2 diabetes: new strategies of treatment and monitoring.

Kasper Rossing1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17521525

Source DB:  PubMed          Journal:  Dan Med Bull        ISSN: 0907-8916


× No keyword cloud information.
  5 in total

Review 1.  Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease.

Authors:  Cécile Caubet; Chrystelle Lacroix; Stéphane Decramer; Jens Drube; Jochen H H Ehrich; Harald Mischak; Jean-Loup Bascands; Joost P Schanstra
Journal:  Pediatr Nephrol       Date:  2009-07-15       Impact factor: 3.714

Review 2.  Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.

Authors:  Jochen Metzger; Peter B Luppa; David M Good; Harald Mischak
Journal:  Crit Rev Clin Lab Sci       Date:  2009       Impact factor: 6.250

Review 3.  The effects of GLP-1 analogues, DPP-4 inhibitors and SGLT2 inhibitors on the renal system.

Authors:  Guntram Schernthaner; Carl Erik Mogensen; Gerit-Holger Schernthaner
Journal:  Diab Vasc Dis Res       Date:  2014-09       Impact factor: 3.291

4.  Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria.

Authors:  Frederik Persson; Peter Rossing; Henrik Reinhard; Tina Juhl; Coen D A Stehouwer; Casper Schalkwijk; A H Jan Danser; Frans Boomsma; Erik Frandsen; Hans-Henrik Parving
Journal:  Diabetes Care       Date:  2009-07-08       Impact factor: 19.112

5.  Clinical Trajectories, Healthcare Resource Use, and Costs of Diabetic Nephropathy Among Patients with Type 2 Diabetes: A Latent Class Analysis.

Authors:  Ruixuan Jiang; Ernest Law; Zhou Zhou; Hongbo Yang; Eric Q Wu; Raafat Seifeldin
Journal:  Diabetes Ther       Date:  2018-03-29       Impact factor: 2.945

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.